Skip to main content
Equibles

PRELUDE CAPITAL MANAGEMENT, LLC

Position in TXG — 10x Genomics, Inc.

CIK 1387508 NEW YORK, NY
Back to TXG Full portfolio

Position in TXG

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,013,408
+$189,012 QoQ
Shares Held
78,597
-40.9% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TXG Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $19,983,923 across 14 Medical Devices names. TXG ranks #2 (15.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PEN
Penumbra Inc
 36,381 $11,487,300
2 TXG
10x Genomics, Inc.
This page 		78,597 $3,013,408
3
115,133 $2,864,509
4 BIO
Bio-Rad Laboratories, Inc.
 2,015 $591,624
5 TNDM
Tandem Diabetes Care Inc
 19,002 $286,740
6 DXCM
Dexcom Inc
 3,857 $259,768
7 RXST
RxSight, Inc.
 51,600 $248,712
8 BVS
Bioventus Inc.
 25,780 $243,363

All Filings in TXG

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,013,408 78,597
2026-03-31 $2,824,396 133,038
2025-12-31 $1,500,242 91,983
2025-09-30 $867,842 74,238
2025-06-30 $614,539 53,069
2024-03-31 $215,910 5,753
2021-09-30 $201,773 1,386
2021-06-30 $589,026 3,008
2021-03-31 $428,246 2,366
2020-12-31 $379,912 2,683
2020-09-30 $272,924 2,189
2020-06-30 $84,844 950